Nathalie A. Lokker

Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.

Nathalie A. Lokker, Carol M. Sullivan, Stanley J. Hollenbach et al. · PubMed · 2002 · 436 citations

Pathology, Novel Pdgf-c, Pdgf Family +16

PDGF-D, a new protease-activated growth factor

William J. LaRochelle, Michael Jeffers, William F. McDonald et al. · Nature Cell Biology · 2001 · 414 citations

Growth Hormone, Human Growth, Fibroblast Growth Factor +4

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Louise Kelly, Jin‐Chen Yu, Christina Boulton et al. · Cancer Cell · 2002 · 307 citations · Full text

Hematological Malignancy, Novel Therapy, Medicine +9

Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.

Nathalie A. Lokker, Melanie R. Mark, E. Luis et al. · The EMBO Journal · 1992 · 293 citations · Full text

Hepatocyte Growth Factor, Signal Transduction, Hepatology +10

Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations

Hanna S. Radomska, Daniela S. Daniela Sanchez Bassères, Rui Zheng et al. · The Journal of Experimental Medicine · 2006 · 194 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Myeloid Neoplasia +16